5-Methyl-2-(piperidin-4-yloxy)pyridine, 98%, 100mg

7-Chloro-1,6-dimethyl-2,3,4,5-tetrahydro-1H-azepine, 95.0%, 1g

3,4-Difluoro-4'-(trans-4-propylcyclohexyl)biphenyl>98.0%(GC)25g

(S,S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride, 97%, 1g

Ethylendiamin-tetraessigsäure, Dikaliumsalz, min. 99 %, p.a., 500 g, kunststoffverpackung.

5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-2-methoxypyridine, 95.0%, 5g

6-Fluoro-2-morpholinonicotinic acid, 97%, 1g

7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one, 95.0%, 250mg

Ethyl 3-Amino-1-methyl-1H-pyrazole-4-carboxylate, 95.0%, 25g

(-)-Phenyl(trifluoromethyl)carbinol, 95.0%, 10mg

4,4,4-Trifluoro-1-(2-naphthyl)-1,3-butanedione, 98.0%, 5g

Methyl pyrrolo[1,2-b]pyridazine-6-carboxylate, 97%, 100mg

2-Methylquinoline-4,6-diamine, 95+%, 100mg